The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant
- PMID: 29282452
- DOI: 10.1001/jamapsychiatry.2017.3738
The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant
Comment on
-
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.JAMA Psychiatry. 2018 Feb 1;75(2):139-148. doi: 10.1001/jamapsychiatry.2017.3739. JAMA Psychiatry. 2018. PMID: 29282469 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical